Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Maria L. Lozano, Bertrand Godeau, John Grainger, Axel Matzdorff, Francesco Rodeghiero, Jane Hippenmeyer & David J. Kuter. (2020) Romiplostim in adults with newly diagnosed or persistent immune thrombocytopenia. Expert Review of Hematology 13:12, pages 1319-1332.
Read now
Read now
Joyce Tumaini Massaro, Yanhui Chen & Zhongling Ke. (2019) Efficacy and safety of thrombopoietin receptor agonists in children with chronic immune thrombocytopenic purpura: meta-analysis. Platelets 30:7, pages 828-835.
Read now
Read now
Shanshan Li, Jingbo Shao, Min Xia, Na Zhang, Jingwei Yang, Hong Li & Hui Jiang. (2018) Thrombopoietin and its receptor expression in pediatric patients with chronic immune thrombocytopenia. Hematology 23:7, pages 433-438.
Read now
Read now
David Buchbinder, Diane Nugent & Loan Hsieh. (2017) Spotlight on romiplostim in the treatment of children with chronic immune thrombocytopenia: design, development, and potential place in therapy. Drug Design, Development and Therapy 11, pages 1055-1063.
Read now
Read now
Jiaxing Zhang, Yi Liang, Yuan Ai, Juan Xie, Youping Li & Wenyi Zheng. (2017) Thrombopoietin-receptor agonists for children with immune thrombocytopenia: a systematic review. Expert Opinion on Pharmacotherapy 18:15, pages 1543-1551.
Read now
Read now
Articles from other publishers (18)
John D. Grainger, Thomas Kühne, Jane Hippenmeyer & Nichola Cooper. (2021) Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia. Annals of Hematology 100:9, pages 2143-2154.
Crossref
Crossref
Giuseppe Lassandro, Valentina Palladino, Giovanni C.D. Vecchio, Viviana V. Palmieri, Paola C. Corallo, Maria F. Faienza & Paola Giordano. (2021) Thrombopoietin Receptor Agonists in Children with Immune Thrombocytopenia: A New Therapeutic Era. Endocrine, Metabolic & Immune Disorders - Drug Targets 21:3, pages 397-406.
Crossref
Crossref
登媛 岳. (2021) Research Progress and Drug Evaluation of Immunological Thrombocytopenia in Children. Pharmacy Information 10:05, pages 252-260.
Crossref
Crossref
Amy Cruickshank & Jason Koury. (2019) Novel approach to decrease platelet exposure in a pediatric Jehovah Witness patient. Pediatric Blood & Cancer 66:11.
Crossref
Crossref
Jiaxing Zhang, Yi Liang, Yuan Ai, Xiaosi Li, Juan Xie, Youping Li, Wenyi Zheng & Rui He. (2018) Eltrombopag versus romiplostim in treatment of children with persistent or chronic immune thrombocytopenia: a systematic review incorporating an indirect-comparison meta-analysis. Scientific Reports 8:1.
Crossref
Crossref
Rita Consolini, Giorgio Costagliola & Davide Spatafora. (2017) The Centenary of Immune Thrombocytopenia—Part 2: Revising Diagnostic and Therapeutic Approach. Frontiers in Pediatrics 5.
Crossref
Crossref
Elena V. Suntsova, Irina M. Demina, Anastasia A. Ignatova, Nikolay M. Ershov, Natalia M. Trubina, Juliya Dobrynina, Irina V. Serkova, Zhanna S. Supik, Ekaterina V. Orekhova, Lili A. Hachatryan, Natalia N. Kotskaya, Aleksey V. Pshonkin, Aleksey A. Maschan, Galina A. Novichkova & Mikhail A. Panteleev. (2017) Bleeding tendency and platelet function during treatment with romiplostim in children with severe immune thrombocytopenic purpura. International Journal of Hematology 105:6, pages 841-848.
Crossref
Crossref
Usha Gutti, Satya Ratan Pasupuleti, Itishri Sahu, Aneesh Kotipalli, Ram Babu Undi, Ravinder Kandi, Raja Gopal Venakata Saladi & Ravi Kumar Gutti. (2016) Erythropoietin and thrombopoietin mimetics: Natural alternatives to erythrocyte and platelet disorders. Critical Reviews in Oncology/Hematology 108, pages 175-186.
Crossref
Crossref
Angelica Maria Garzon & William Beau Mitchell. (2015) Use of Thrombopoietin Receptor Agonists in Childhood Immune Thrombocytopenia. Frontiers in Pediatrics 3.
Crossref
Crossref
M. Pasquet, N. Aladjidi, C. Guitton, T. Leblanc, Y. Pérel & G. Leverger. (2015) Recommandations d’utilisation des agonistes du récepteur de la thrombopoïétine dans le purpura thrombopénique immunologique de l’enfant et de l’adolescent. Revue d'Oncologie Hématologie Pédiatrique 3:1, pages 4-12.
Crossref
Crossref
Thomas Kühne. (2015) Treatment of Pediatric Primary Immune Thrombocytopenia With Thrombopoietin Receptor Agonists. Seminars in Hematology 52:1, pages 25-30.
Crossref
Crossref
Kei Minowa, Katsuhiro Arai, Mureo Kasahara, Seisuke Sakamoto, Hirotaka Shimizu, Natsuko Nakano, Reiko Ito, Naho Obayashi, Atsuko Nakazawa & Akira Ishiguro. (2014) Romiplostim treatment allows for platelet transfusion‐free liver transplantation in pediatric thrombocytopenic patient with primary sclerosing cholangitis. Pediatric Transplantation 18:6.
Crossref
Crossref
George R. Buchanan. (2014) Immune Thrombocytopenia during Childhood: New Approaches to Classification and Management. The Journal of Pediatrics 165:3, pages 437-439.
Crossref
Crossref
Markus G. Seidel, Christian Urban, Johanna Sipurzynski, Christine Beham-Schmid, Herwig Lackner & Martin Benesch. (2014) High response rate but short-term effect of romiplostim in paediatric refractory chronic immune thrombocytopenia. British Journal of Haematology 165:3, pages 419-421.
Crossref
Crossref
Veerle Labarque & Chris Van Geet. (2014) Clinical practice: immune thrombocytopenia in paediatrics. European Journal of Pediatrics 173:2, pages 163-172.
Crossref
Crossref
Marlène Pasquet, Nathalie Aladjidi, Corinne Guiton, Mary-France Courcoux, Martine Munzer, Anne Auvrignon, Patrick Lutz, Stéphane Ducassou, Gwennaelle LeRoy, Caroline Munzer & Guy Leverger. (2014) Romiplostim in children with chronic immune thrombocytopenia (ITP): the French Experience. British Journal of Haematology 164:2, pages 266-271.
Crossref
Crossref
Alexandra Schifferli & Thomas Kühne. (2013) Chronic Immune Thrombocytopenia in Children: Who Needs Splenectomy?. Seminars in Hematology 50, pages S58-S62.
Crossref
Crossref
Janna M. Journeycake. (2012) Childhood immune thrombocytopenia: role of rituximab, recombinant thrombopoietin, and other new therapeutics. Hematology 2012:1, pages 444-449.
Crossref
Crossref